NK cell

(redirected from NK cells)
Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia.
Related to NK cells: T cells, MHC, Macrophages

NK cell

(ĕn′kā′)
Mentioned in ?
References in periodicals archive ?
We believe our proprietary iPSC product platform, which we are applying to consistently produce large quantities of uniform, well-characterized NK cells and T cells from clonal master iPSC lines, can transform cell therapy from a single-dose, patient-restricted process to a multi-dose, off-the-shelf product paradigm.
GCLC has developed the technology and expertise for the mass production of human NK cells by successfully conducting a first-in-human clinical trial using healthy donor-derived allogeneic NK cells and by developing CAR-NKs to enhance anti-tumor specificity and efficacy.
Green Cross LabCell has reportedly developed the technology and expertise for the mass production of human NK cells by successfully conducting a first-in-human clinical trial using healthy donor-derived allogeneic NK cells and by developing CAR-NKs to enhance anti-tumor specificity and efficacy.
Kaufman said NK cells have the inherent ability to target a diversity of stress-induced ligands on tumor cells and can be safely administered without the need for individualized patient matching.
Biobran is a modified arabinoxylan rice bran, enzymatically treated with an extract from shitake mushroom mycelia that permits, unlike other fibers, quick intestinal absorption into the bloodstream, activating a number of cytokines that, in turn, activate NK cells, dendritic cells, and macrophages.
Under influence of sex steroids, there is a marked increase of a unique population of endometrial natural killer (NK) cells and lymphocytes, derived predominantly from a subset of peripheral blood NK cells and subsequently recruited to the uterus.
Investigators from the Universities of Gothenburg, Sweden and Rome, Italy reported that functional NK cells are clinically relevant anti-leukemic effector cells in AML patients who received treatment with Ceplene/IL-2.
8,9) There are many quantitative and qualitative changes in NK cells in diabetic patients.
Background: Vascular Endothelial Growth Factor and NK cells have an interrelated role in angiogenesis that is critical for placentation and success of in vitro fertilization.
The report covers autologous and allogeneic engineered chimeric antigen receptor (CAR) and T-cell receptor (TCR) T-cell therapy candidates as well as natural killer (NK) cell and CAR engineered NK cells in research and development by biopharmaceutical companies.
Primary mediator of tissue damage is excessive cytokine production by NK cells, macrophages and CTLs.
By building on our knowledge of the activating receptor NKp46, we have generated a technology to specifically induce tumor killing by NK cells.